Financials
Financial year 2025
QUERCUS LABO from Gent, company number BE0457113884, closed financial year 2025 with a result of € 739,004 after tax. For that financial year QUERCUS LABO recorded a gross margin of € 2.8 million and equity of € 2.5 million. Compared with financial year 2024, the result moved from € 105,697 to € 739,004. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2026.
€ 2.5 million
▲ 43% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 739,004
▲ € 633,307 vs 2024
Profit after tax over the fiscal year.
€ 515,452
▲ 34% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1.8 million.
People and assets in 2025
24.7
▲ 1.4 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 1.5 million
▲ 6% vs 2024
€ 59,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 189,772
▲ 96% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1.4 million
▲ 30% vs 2024
€ 125,706 is repaid this year. At this pace the long-term loan is gone in ≈ 11 years.
€ 322,437
▲ 114% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 316,507
▲ 85% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 2,087,401 | € 1,606,305 | € 1,864,030 | € 2,831,014 | ▲ 52% |
| Profit after taxes | € 590,251 | € 71,594 | € 105,697 | € 739,004 | ▲ € 633,307 |
| Equity | € 1,538,922 | € 1,610,516 | € 1,716,213 | € 2,455,217 | ▲ 43% |
| Total debts | € 1,709,363 | € 1,740,274 | € 1,426,251 | € 2,066,933 | ▲ 45% |
| Cash | € 473,107 | € 176,434 | € 384,536 | € 515,452 | ▲ 34% |
| Land & buildings | € 1,272,878 | € 1,444,278 | € 1,481,106 | € 2,110,582 | ▲ 43% |
| Retained profit | € 907,922 | € 979,516 | € 1,085,213 | € 1,824,217 | ▲ 68% |
| Bank debt | € 1,274,377 | € 1,148,389 | € 1,093,313 | € 1,424,840 | ▲ 30% |
| Balance sheet total | € 3,248,285 | € 3,350,790 | € 3,142,464 | € 4,522,150 | ▲ 44% |
| Employees (FTE) | 18.1 | 20.2 | 23.3 | 24.7 | ▲ 1.4 |
Key figures of QUERCUS LABO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to QUERCUS LABO?
What happened at QUERCUS LABO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 739,004 (▲ € 633,307 vs 2024). Source: NBB ↗
- Patricia Peeters became a director. NBB
- Tom Lokermans became a director. NBB
- Bart Van Acker became a director. NBB
- Yves Peeraer became a director. NBB
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
From € 590,251 profit in 2022 to € 739,004 profit in 2025.
Paid € 521,776 in corporate taxes since 2022.
Best year ever: 2025, with € 739,004 profit.
On average € 114,600 of value added per employee in 2025.
A new publication or filing at QUERCUS LABO? We notify you, reason included.
Follow QUERCUS LABODatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of PAVYRA, QbD Growth comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
QUERCUS LABOBehind QUERCUS LABO are Patricia Peeters, Tom Lokermans, Bart Van Acker and Yves Peeraer. The shares are held by PAVYRA (50%) and QbD Growth (50%).
Directors
According to the 2025 annual accounts
Patricia Peeters
Director
since 2021
Tom Lokermans
Director
since 2021
Bart Van Acker
Director
Also active at: Qarad EC-REP, QARAD, Quality for You, QbD Wallonia, SIMABS, QbD Clinical Holding, PERSOMED, HEALTHTOMARKET +5 more
since 2021
Yves Peeraer
Director
since 2021
Shareholders
50%
50%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Wijmenstraat 21P
9030 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
COMBELL-AS, BE
Website info
Features
Security
Details
- Company number
- 0457.113.884
- VAT number
- BE 0457.113.884
- Registered office
- Wijmenstraat 21P, 9030 Gent
- Names & denominations
- QUERCUS LABO
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 January 1996
- Peppol
- Active · Active since 12 Dec 2025
- Contact
- quercus.be
- Activities · NACE
Overige technische testen en toetsen
Technische testen en analyses
Activiteiten van medische beeldvorming en medische laboratoria
Medische laboratoria
Activiteiten van medische laboratoria